Anne Kirby
Net worth: - $ as of 2023-09-29
Career history of Anne Kirby
Former positions of Anne Kirby
Companies | Position | Start | End |
---|---|---|---|
REGNUM CORP. | Director/Board Member | 2021-04-06 | 2023-05-22 |
Chief Executive Officer | 2021-04-06 | 2023-05-22 | |
President | 2021-04-06 | 2023-05-22 | |
Corporate Secretary | 2021-04-06 | 2023-05-22 | |
Vyera Pharmaceuticals LLC
Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 2018-09-30 | 2021-03-31 |
Training of Anne Kirby
University of Akron | Masters Business Admin |
Statistics
International
United States | 4 |
Operational
Corporate Officer/Principal | 1 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
REGNUM CORP. | Health Technology |
Private companies | 1 |
---|---|
Vyera Pharmaceuticals LLC
Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Anne Kirby
- Experience